#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Skin cancer Cervix carcinoma recurrent Cystic fibrosis respiratory infection suppression Dermatomyositis B-cell lymphoma recurrent Prader-Willi syndrome Metachromatic leukodystrophy Oesophageal achalasia Pleomorphic liposarcoma Glioblastoma Acute promyelocytic leukaemia Congenital ectodermal dysplasia Scleroderma associated digital ulcer Colitis ulcerative Neurodevelopmental disorder More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Basic Information Angelman’s syndrome IgA nephropathy – Treatment Mucopolysaccharidosis III – Treatment Cholangitis sclerosing – Basic Information Medulloblastoma – Life with Disease Haemophilia A without inhibitors Marfan’s syndrome Chondrosarcoma metastatic – Diagnostics Focal segmental glomerulosclerosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mycophenolic Acid Sabirnetug Dexibuprofen COLESEVELAM HYDROCHLORIDE TRIACYLGLYCEROL LIPASE Jnj-81241459 Camlipixant Cerebrolysin Concentrate Clofarabine Oxymetazoline Hydrochloride Polydextrose Doxazosin Art0380 Mesilate Ddcart‐Cd19 Mk-6194 Phleum Pratense Pollen Extract Indometacin Teprotumumab RUBIDIUM CHLORIDE Lysine Aspirin More therapies…

    Learn about Your Condition

    Hypoxia Joint stabilisation Portal hypertension Neuroblastoma Carpal tunnel syndrome Osteoarthritis Non-Hodgkin's lymphoma Myxofibrosarcoma Mitral valve incompetence Bile duct adenocarcinoma Polymyalgia rheumatica Death neonatal Cardiac arrest Haemodialysis Pleomorphic liposarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Palmoplantar pustulosis

  • A Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Investigated Drugs:
    • Bimekizumab
    Czechia Denmark France Germany Hungary Italy +2

  • Study of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial

    Recruiting

    2 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Germany Poland

  • Study on the Effects of Sonelokimab for Patients with Moderate-to-Severe Palmoplantar Pustulosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Palmoplantar pustulosis
    Investigated Drugs:
    • Sonelokimab
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!